Mentions:
1: Wes Streeting (Lab - Ilford North) and those tyrants in Action on Smoking and Health, the British Heart Foundation, Cancer Research UK, Diabetes - Speech Link
2: Maggie Throup (Con - Erewash) It causes 15 different types of cancer, and it is linked to cardiovascular disease, strokes, diabetes - Speech Link
Asked by: Burnett, Alexander (Scottish Conservative and Unionist Party - Aberdeenshire West)
Question
To ask the Scottish Government what pathways of support and treatment are available to eating disorder patients who may require non-standardised care.
Answered by Todd, Maree - Minister for Social Care, Mental Wellbeing and Sport
We are committed to supporting people to access the right care at the right time and having support in place to respond to the whole person needs of those who suffer from an eating disorder. That is why in 2023-24 we allocated £55.5 million to Health Boards to improve the quality and delivery of mental health and psychological services for all, including eating disorder services.
The Scottish Government has recently developed a draft National Specification for the Care and Treatment of Eating Disorders in Scotland which will be finalised later this year. It clearly outlines that we would expect services to have specialist pathways and work jointly with other services to care for anyone with co-occurring considerations such as neurodiversity, pregnancy, diabetes etc.
The vast majority of people with eating disorders will be treated in the community, with support provided by primary care or community mental health teams, and with support links to specialist hospital or voluntary sector care where appropriate.
We have also provided Beat, the UK’s largest Eating Disorder charity, with over £600,000 to provide a range of support services for those impacted by an eating disorder.
Asked by: Regan, Ash (Alba Party - Edinburgh Eastern)
Question
To ask the Scottish Government what action it is taking to address the reportedly significant waiting times for access to diabetes technology, such as insulin pumps and continuous glucose monitoring systems, for people with type 1 diabetes across Scotland, including in NHS Lothian, and what steps are being taken to meet the national targets and align with reported advancements in NHS England.
Answered by Minto, Jenni - Minister for Public Health and Women's Health
The Scottish Government’s Diabetes Improvement Plan contains a key commitment to further increase access to existing and emerging diabetes technologies.
Between 2016 and 2022, we invested £29.6 million of additional funding specifically to support the increased provision of insulin pumps and continuous glucose monitors (CGMs) and emerging technologies such as closed loop systems.
We have also invested a further £350,000 through the Accelerated National Innovation Adoption pathway to help roll out the technology faster and more efficiently across Scotland. A key focus of this project is reducing regional variation and making access to technology more equitable across Scotland.
We continue to work closely the Diabetes Managed Clinical Networks (MCNs) within each Board, including NHS Lothian, to identify and resolve any issues raised by NHS Boards regarding accessing diabetes technologies, to ensure that all available resource is targeted to support the needs of local populations.
Asked by: Matt Western (Labour - Warwick and Leamington)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to ensure people with diabetes can continue to access the insulin they need.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
We are aware of supply issues with some insulin products, however the vast majority are in stock. Comprehensive management guidance on alternative products has been issued to the National Health Service where needed.
The medicine supply chain is highly regulated, complex, and global. Supply disruption is an issue which affects the United Kingdom, as well as the other countries around the world, and it can have a variety of causes, including manufacturing issues, problems with access to raw ingredients, and sudden spikes in demand.
There is a team within the Department that deals specifically with medicine supply problems. It has well-established tools and processes to manage medicine supply issues, working closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England, and others operating in the supply chain, to help prevent shortages and expedite resupply as soon as possible, to ensure that the risks to patients are minimised.
Apr. 12 2024
Source Page: Non-technical summaries granted in 2024Found: Optimising Islet Transplantation in Type 1 Diabetes 707 84.
Apr. 10 2024
Source Page: Partnerships for People and Place: learning and evaluation reportFound: For example, DHSC central government partners described how funding for diabetes and heart disease is
Written Evidence Apr. 09 2024
Inquiry: Food, Diet and ObesityFound: developing obesity, as well as more at risk of complications in pregnancy including gestational diabetes
Apr. 09 2024
Source Page: Employing disabled people: Disability Confident and CIPD manager’s guideFound: by their impairment, for example, instead of saying ‘she is diabetic’ it is better to say ‘she has diabetes